As of Sep 01
| -0.71 / -2.17%|
The 8 analysts offering 12-month price forecasts for PharMerica Corp have a median target of 38.00, with a high estimate of 40.00 and a low estimate of 22.00. The median estimate represents a +18.71% increase from the last price of 32.01.
The current consensus among 8 polled investment analysts is to Buy stock in PharMerica Corp. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.